Biodesix Debt-to-Equity Ratio Growth & History (BDSX)
Biodesix's debt-to-equity ratio was 3.14 for fiscal 2024.
View full Biodesix company overviewBiodesix annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | 3.14 | −11.16 | −78.03% |
| 2023 | 2023-12-31 | 14.30 | 12.51 | +698.02% |
| 2022 | 2022-12-31 | 1.79 | 1.21 | +205.39% |
| 2021 | 2021-12-31 | 0.59 | −0.10 | −13.98% |
| 2020 | 2020-12-31 | 0.68 | — | — |
Biodesix quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 8.20 | −58.02 | −87.62% |
| Q1 2026 | 2026-03-31 | 8.23 | 2.30 | +38.71% |
| Q2 2025 | 2025-06-30 | 66.22 | 64.41 | +3547.46% |
| Q1 2025 | 2025-03-31 | 5.93 | — | — |
| Q4 2024 | 2024-12-31 | 3.14 | −11.16 | −78.03% |
| Q3 2024 | 2024-09-30 | 2.36 | — | — |
| Q2 2024 | 2024-06-30 | 1.82 | — | — |
| Q4 2023 | 2023-12-31 | 14.30 | 12.51 | +698.02% |
| Q1 2023 | 2023-03-31 | 9.65 | 8.05 | +503.13% |
| Q4 2022 | 2022-12-31 | 1.79 | 1.21 | +205.39% |
| Q2 2022 | 2022-06-30 | 3.59 | 2.30 | +178.89% |
| Q1 2022 | 2022-03-31 | 1.60 | 0.69 | +76.01% |
| Q4 2021 | 2021-12-31 | 0.59 | −0.10 | −13.98% |
| Q3 2021 | 2021-09-30 | 1.97 | — | — |
| Q2 2021 | 2021-06-30 | 1.29 | — | — |
| Q1 2021 | 2021-03-31 | 0.91 | — | — |
| Q4 2020 | 2020-12-31 | 0.68 | — | — |
Biodesix debt-to-equity ratio trends
Between the periods ended 2020-12-31 and 2024-12-31, Biodesix's debt-to-equity ratio increased from 0.68 to 3.14, a change of 2.46. The latest reported quarter, Q2 2026, shows 8.20.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biodesix source filings ↗